Literature DB >> 25675995

Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expression.

Hong Jin1, Milena A Gebska1, Ilya O Blokhin1, Katina M Wilson1, Pimonrat Ketsawatsomkron1, Anil K Chauhan1, Henry L Keen1, Curt D Sigmund1, Steven R Lentz2.   

Abstract

OBJECTIVE: We tested the hypothesis that endothelial peroxisome proliferator-activated receptor-γ protects against vascular thrombosis using a transgenic mouse model expressing a peroxisome proliferator-activated receptor-γ mutant (E-V290M) selectively in endothelium. APPROACH AND
RESULTS: The time to occlusive thrombosis of the carotid artery was significantly shortened in E-V290M mice compared with nontransgenic littermates after either chemical injury with ferric chloride (5.1 ± 0.2 versus 10.1 ± 3.3 minutes; P=0.01) or photochemical injury with rose bengal (48 ± 9 versus 74 ± 9 minutes; P=0.04). Gene set enrichment analysis demonstrated the upregulation of NF-κB target genes, including P-selectin, in aortic endothelial cells from E-V290M mice (P<0.001). Plasma P-selectin and carotid artery P-selectin mRNA were elevated in E-V290M mice (P<0.05). P-selectin-dependent leukocyte rolling on mesenteric venules was increased in E-V290M mice compared with nontransgenic mice (53 ± 8 versus 25 ± 7 per minute; P=0.02). The shortened time to arterial occlusion in E-V290M mice was reversed by administration of P-selectin-blocking antibodies or neutrophil-depleting antibodies (P=0.04 and P=0.02, respectively) before photochemical injury.
CONCLUSIONS: Endothelial peroxisome proliferator-activated receptor-γ protects against thrombosis through a mechanism that involves downregulation of P-selectin expression and diminished P-selectin-mediated leukocyte-endothelial interactions.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  P-selectin; endothelium; thrombosis

Mesh:

Substances:

Year:  2015        PMID: 25675995      PMCID: PMC4376629          DOI: 10.1161/ATVBAHA.115.305378

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

Review 1.  PPARs and molecular mechanisms of transrepression.

Authors:  Mercedes Ricote; Christopher K Glass
Journal:  Biochim Biophys Acta       Date:  2007-03-12

2.  Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes.

Authors:  Gang Li; Todd Leff
Journal:  Mol Endocrinol       Date:  2007-01-16

3.  Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes.

Authors:  Howard N Hodis; Wendy J Mack; Ling Zheng; Yanjie Li; Mina Torres; Diego Sevilla; Yolanda Stewart; Barbara Hollen; Karla Garcia; Petar Alaupovic; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

Review 4.  Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.

Authors:  Arya M Sharma; Bart Staels
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

5.  Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.

Authors:  Theodore Mazzone; Peter M Meyer; Steven B Feinstein; Michael H Davidson; George T Kondos; Ralph B D'Agostino; Alfonso Perez; Jean-Claude Provost; Steven M Haffner
Journal:  JAMA       Date:  2006-11-13       Impact factor: 56.272

6.  Extracellular DNA traps promote thrombosis.

Authors:  Tobias A Fuchs; Alexander Brill; Daniel Duerschmied; Daphne Schatzberg; Marc Monestier; Daniel D Myers; Shirley K Wrobleski; Thomas W Wakefield; John H Hartwig; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

Review 7.  Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.

Authors:  Sheng Zhong Duan; Michael G Usher; Richard M Mortensen
Journal:  Circ Res       Date:  2008-02-15       Impact factor: 17.367

Review 8.  Fat and beyond: the diverse biology of PPARgamma.

Authors:  Peter Tontonoz; Bruce M Spiegelman
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

9.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

Review 10.  Murine models of vascular thrombosis (Eitzman series).

Authors:  Randal J Westrick; Mary E Winn; Daniel T Eitzman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-28       Impact factor: 8.311

View more
  16 in total

Review 1.  Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Jakaria; Abdullah Al Mamun; Kamal Niaz; Md Shah Amran; George E Barreto; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2019-05-04       Impact factor: 3.911

2.  P-selectin can promote thrombus propagation independently of both von Willebrand factor and thrombospondin-1 in mice.

Authors:  P Prakash; M K Nayak; A K Chauhan
Journal:  J Thromb Haemost       Date:  2017-02-03       Impact factor: 5.824

3.  Protein methionine oxidation augments reperfusion injury in acute ischemic stroke.

Authors:  Sean X Gu; Ilya O Blokhin; Katina M Wilson; Nirav Dhanesha; Prakash Doddapattar; Isabella M Grumbach; Anil K Chauhan; Steven R Lentz
Journal:  JCI Insight       Date:  2016-05-19

Review 4.  Update on cardiovascular disease in lupus.

Authors:  Laura B Lewandowski; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

5.  The Transcription Factor IRF6 Co-Represses PPARγ-Mediated Cytoprotection in Ischemic Cerebrovascular Endothelial Cells.

Authors:  Rongzhong Huang; Zicheng Hu; Yuxing Feng; Lehua Yu; Xingsheng Li
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

6.  The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway.

Authors:  Umesh B Mahajan; Govind Chandrayan; Chandragouda R Patil; Dharamvir Singh Arya; Kapil Suchal; Yogeeta O Agrawal; Shreesh Ojha; Sameer N Goyal
Journal:  Int J Mol Sci       Date:  2017-04-04       Impact factor: 5.923

7.  A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling.

Authors:  Ying-Ying Zhang; Zi-de Zhao; Peng-Yun Kong; Lin Gao; Ya-Nan Yu; Jun Liu; Peng-Qian Wang; Bing Li; Xiao-Xu Zhang; Li-Qiang Yang; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2020-02-12       Impact factor: 6.150

8.  Omega-9 Oleic Acid, the Main Compound of Olive Oil, Mitigates Inflammation during Experimental Sepsis.

Authors:  Isabel Matos Medeiros-de-Moraes; Cassiano Felippe Gonçalves-de-Albuquerque; Angela R M Kurz; Flora Magno de Jesus Oliveira; Victor Hugo Pereira de Abreu; Rafael Carvalho Torres; Vinícius Frias Carvalho; Vanessa Estato; Patrícia Torres Bozza; Markus Sperandio; Hugo Caire de Castro-Faria-Neto; Adriana Ribeiro Silva
Journal:  Oxid Med Cell Longev       Date:  2018-11-13       Impact factor: 6.543

9.  Rosuvastatin relieves myocardial ischemia/reperfusion injury by upregulating PPAR‑γ and UCP2.

Authors:  Ling Wang; Rong Lin; Langtao Guo; Meiman Hong
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

10.  The Case for Endothelial Preservation via Pressure-Regulated Distension in the Preparation of Autologous Saphenous Vein Conduits in Cardiac and Peripheral Bypass Operations.

Authors:  Eric S Wise; Colleen M Brophy
Journal:  Front Surg       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.